BG106719A - Бициклични аминокиселини като фармацевтични средства - Google Patents

Бициклични аминокиселини като фармацевтични средства Download PDF

Info

Publication number
BG106719A
BG106719A BG106719A BG10671902A BG106719A BG 106719 A BG106719 A BG 106719A BG 106719 A BG106719 A BG 106719A BG 10671902 A BG10671902 A BG 10671902A BG 106719 A BG106719 A BG 106719A
Authority
BG
Bulgaria
Prior art keywords
acetic acid
aminomethylbicyclo
compound
hept
aminomethyl
Prior art date
Application number
BG106719A
Other languages
Bulgarian (bg)
English (en)
Inventor
Justin Bryans
David Blakemore
Simon Osborne
Jean-Marie Receveur
Original Assignee
Warner-Lambert Company Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc
Publication of BG106719A publication Critical patent/BG106719A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/18—All rings being cycloaliphatic the ring system containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/20—All rings being cycloaliphatic the ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/22—All rings being cycloaliphatic the ring system containing eight carbon atoms, e.g. pentalene
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
BG106719A 1999-10-20 2002-05-20 Бициклични аминокиселини като фармацевтични средства BG106719A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16072599P 1999-10-20 1999-10-20
PCT/US2000/028687 WO2001028978A1 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Publications (1)

Publication Number Publication Date
BG106719A true BG106719A (bg) 2003-02-28

Family

ID=22578159

Family Applications (2)

Application Number Title Priority Date Filing Date
BG106719A BG106719A (bg) 1999-10-20 2002-05-20 Бициклични аминокиселини като фармацевтични средства
BG108860A BG108860A (en) 1999-10-20 2002-05-20 BICYCLIC AMINO ACIDS, PHARMACEUTICAL COMPOSITION, AND THE USE OF THEM

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG108860A BG108860A (en) 1999-10-20 2002-05-20 BICYCLIC AMINO ACIDS, PHARMACEUTICAL COMPOSITION, AND THE USE OF THEM

Country Status (50)

Country Link
US (2) US6689906B1 (cs)
EP (2) EP1226110B1 (cs)
JP (2) JP3632191B2 (cs)
KR (2) KR100593349B1 (cs)
CN (1) CN1165518C (cs)
AP (2) AP2002002517A0 (cs)
AR (2) AR026087A1 (cs)
AT (2) ATE293590T1 (cs)
AU (2) AU778871B2 (cs)
BG (2) BG106719A (cs)
BR (1) BR0014972B1 (cs)
CA (1) CA2386297C (cs)
CO (1) CO5280060A1 (cs)
CR (1) CR6620A (cs)
CU (1) CU23112A3 (cs)
CZ (1) CZ295960B6 (cs)
DE (2) DE60034157T2 (cs)
DO (1) DOP2000000083A (cs)
DZ (1) DZ3197A1 (cs)
EA (1) EA005206B1 (cs)
EC (1) ECSP045393A (cs)
EE (1) EE200200211A (cs)
ES (2) ES2237464T3 (cs)
GE (1) GEP20043297B (cs)
GT (2) GT200000183A (cs)
HK (1) HK1049826B (cs)
HN (1) HN2000000224A (cs)
HR (2) HRP20020428B1 (cs)
HU (1) HUP0203325A3 (cs)
IL (3) IL149143A0 (cs)
IS (2) IS6348A (cs)
MA (1) MA26842A1 (cs)
MX (1) MXPA02003229A (cs)
MY (1) MY127678A (cs)
NO (2) NO20021780L (cs)
NZ (1) NZ517961A (cs)
OA (1) OA12070A (cs)
PA (1) PA8505201A1 (cs)
PE (1) PE20010740A1 (cs)
PL (1) PL354607A1 (cs)
PT (1) PT1226110E (cs)
SI (1) SI1226110T1 (cs)
SK (1) SK5232002A3 (cs)
SV (1) SV2001000188A (cs)
TR (2) TR200500221T2 (cs)
TW (2) TW200505824A (cs)
UA (1) UA72931C2 (cs)
WO (1) WO2001028978A1 (cs)
YU (2) YU29302A (cs)
ZA (1) ZA200202543B (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
NZ522480A (en) * 2000-06-26 2005-06-24 Warner Lambert Co Gabapentin analogues for sleep disorders
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
EP1226820A1 (en) * 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
OA12504A (en) 2001-04-19 2006-05-29 Warner Lambert Co Fused bicyclic or tricyclic amino acids.
GB2375109A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Process for preparing bicyclic amino acid
GB2375108A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Production of a bicycloheptanone
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
CN1533270A (zh) * 2001-06-11 2004-09-29 ʲŵ�������޹�˾ 具有降低毒性的gaba类似物前药的口服给药剂型
JP2005521664A (ja) * 2002-01-31 2005-07-21 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 耳鳴を治療するためのアルファ２デルタ・リガンド
IL162932A0 (en) * 2002-02-22 2005-11-20 Warner Lambert Co Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
IL165593A0 (en) * 2002-06-27 2006-01-15 Warner Lambert Co Use of an alpha2delta ligand such as gabapentin orpregabalin for treating attention deficit hyperac tivity disorder
US7419981B2 (en) 2002-08-15 2008-09-02 Pfizer Inc. Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
MXPA05001643A (es) * 2002-08-15 2005-04-25 Pfizer Uso terapeutico de aminoacidos biciclicos y triciclicos condensados.
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
WO2004052360A1 (en) 2002-12-11 2004-06-24 Xenoport, Inc. Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
EP1572188A1 (en) 2002-12-13 2005-09-14 Warner-Lambert Company LLC Pregabalin derivatives for the treatment of fibromyalgia and other disorders
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
KR100828218B1 (ko) 2003-09-12 2008-05-07 화이자 인코포레이티드 알파-2-델타 리간드 및 세로토닌/노르아드레날린 재흡수 억제제를 포함하는 조합물
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
ATE511860T1 (de) 2006-12-22 2011-06-15 Recordati Ireland Ltd Kombinationstherapie für erkrankungen der unteren harnwege mit 2 liganden und nsar
MX2010003394A (es) 2007-09-28 2010-04-09 Daiichi Sankyo Co Ltd Derivado de gamma-aminoacido biciclico.
CA2756750C (en) 2009-03-26 2014-05-13 Daiichi Sankyo Company, Limited A method for producing bicyclic .gamma.-amino acid derivative
HUE035366T2 (en) 2011-06-08 2018-05-02 Daiichi Sankyo Co Ltd A method for the preparation of a bicyclic compound by Claisen rearrangement
WO2012169474A1 (ja) 2011-06-08 2012-12-13 第一三共株式会社 イミニウム塩を経由する二環性化合物の製造方法
HUE040225T2 (hu) 2011-12-15 2019-02-28 Daiichi Sankyo Co Ltd Eljárás biciklikus vegyület optikai elválasztására aszimmetrikus katalizátort felhasználva
KR101976891B1 (ko) 2012-04-10 2019-05-09 다이이찌 산쿄 가부시키가이샤 효소를 사용하는 2 고리성 화합물의 광학 분할 방법
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ－胺基酸衍生物及其製造方法
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) * 2021-03-29 2021-06-29 华东理工大学 一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641129A (en) * 1969-06-17 1972-02-08 Merck & Co Inc Antifibrinolytic compounds
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
CU23048A3 (es) 1997-10-27 2005-06-24 Warner Lambert Co Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos

Also Published As

Publication number Publication date
CN1382118A (zh) 2002-11-27
CU23112A3 (es) 2006-02-27
ATE358116T1 (de) 2007-04-15
CA2386297A1 (en) 2001-04-26
JP3632191B2 (ja) 2005-03-23
EP1226110A1 (en) 2002-07-31
PL354607A1 (en) 2004-01-26
BR0014972B1 (pt) 2011-09-06
MXPA02003229A (es) 2002-09-30
SK5232002A3 (en) 2003-07-01
US20040152779A1 (en) 2004-08-05
PA8505201A1 (es) 2002-08-29
HK1049826B (zh) 2005-02-25
AR045456A2 (es) 2005-10-26
CZ295960B6 (cs) 2005-12-14
EP1506955A1 (en) 2005-02-16
EE200200211A (et) 2003-06-16
US6835751B2 (en) 2004-12-28
JP2003512348A (ja) 2003-04-02
IS6348A (is) 2002-04-17
OA12070A (en) 2003-11-10
EP1506955B1 (en) 2007-03-28
TR200201094T2 (tr) 2002-09-23
YU29302A (sh) 2005-06-10
HRP20040709A2 (en) 2004-12-31
NZ517961A (en) 2002-12-20
BG108860A (en) 2006-03-31
WO2001028978A1 (en) 2001-04-26
GEP20043297B (en) 2004-01-12
GT200000183A (es) 2000-10-19
IL149143A0 (en) 2002-11-10
DE60034157D1 (de) 2007-05-10
DE60019628T2 (de) 2006-01-19
PE20010740A1 (es) 2001-07-27
NO20021780D0 (no) 2002-04-16
DE60034157T2 (de) 2007-12-13
ECSP045393A (es) 2004-10-23
TWI225855B (en) 2005-01-01
EP1226110B1 (en) 2005-04-20
PT1226110E (pt) 2005-07-29
IS7497A (is) 2004-10-08
MA26842A1 (fr) 2004-12-20
ZA200202543B (en) 2003-09-23
TR200500221T2 (tr) 2005-03-21
ATE293590T1 (de) 2005-05-15
JP2005036009A (ja) 2005-02-10
JP3744928B2 (ja) 2006-02-15
HRP20020428B1 (en) 2006-02-28
SV2001000188A (es) 2001-09-07
HK1049826A1 (en) 2003-05-30
BR0014972A (pt) 2002-07-16
SI1226110T1 (en) 2005-08-31
GT200000183AA (es) 2005-06-17
EA200200293A1 (ru) 2002-10-31
HRP20020428A2 (en) 2005-02-28
AU2005201268A1 (en) 2005-04-21
TW200505824A (en) 2005-02-16
HUP0203325A2 (hu) 2003-02-28
IL149143A (en) 2007-02-11
KR100593349B1 (ko) 2006-06-26
HUP0203325A3 (en) 2003-12-29
NO20043663L (no) 2002-04-16
ES2237464T3 (es) 2005-08-01
UA72931C2 (uk) 2005-05-16
CA2386297C (en) 2010-02-09
DOP2000000083A (es) 2002-03-30
KR100566462B1 (ko) 2006-03-31
CN1165518C (zh) 2004-09-08
AP2002002517A0 (en) 2002-06-30
HN2000000224A (es) 2001-04-11
KR20020040900A (ko) 2002-05-30
MY127678A (en) 2006-12-29
AR026087A1 (es) 2002-12-26
AU778871B2 (en) 2004-12-23
AU1092001A (en) 2001-04-30
DE60019628D1 (de) 2005-05-25
CO5280060A1 (es) 2003-05-30
US6689906B1 (en) 2004-02-10
YU73004A (sh) 2005-11-28
KR20060013701A (ko) 2006-02-13
ES2282785T3 (es) 2007-10-16
NO20021780L (no) 2002-04-16
DZ3197A1 (fr) 2001-04-26
IL164060A0 (en) 2005-12-18
CZ20021310A3 (cs) 2003-05-14
EA005206B1 (ru) 2004-12-30
AP2004003186A0 (en) 2004-12-31
CR6620A (es) 2004-02-02

Similar Documents

Publication Publication Date Title
BG106719A (bg) Бициклични аминокиселини като фармацевтични средства
JP3756761B2 (ja) 医薬として有用な環状アミノ酸およびその誘導体
US6316638B1 (en) Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
US20050250800A1 (en) Conformationally constrained compounds as pharmaceutical agents
MXPA00009494A (en) Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel